These results are in line with reports of gigaxonin (also known as giant axonal neuropathy) being an E3 ligase substrate adaptor that targets proteins for proteasomal degradation and our findings that MYH3 is inhibited post-transcriptionally in the absence of miR-501. This evidence concerns the gene GAN and giant axonal neuropathy.